Financhill
Buy
52

MNTK Quote, Financials, Valuation and Earnings

Last price:
$1.78
Seasonality move :
-17.13%
Day range:
$1.71 - $1.80
52-week range:
$1.56 - $4.96
Dividend yield:
0%
P/E ratio:
87.70x
P/S ratio:
1.57x
P/B ratio:
0.97x
Volume:
80K
Avg. volume:
173.2K
1-year change:
-55.75%
Market cap:
$251.8M
Revenue:
$175.7M
EPS (TTM):
-$0.06

Analysts' Opinion

  • Consensus Rating
    Montauk Renewables, Inc. has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 3 Hold ratings, and 1 Sell rating.
  • Price Target Upside
    According to analysts' consensus price target of $2.96, Montauk Renewables, Inc. has an estimated upside of 67.37% from its current price of $1.77.
  • Price Target Downside
    According to analysts, the lowest downside price target is $2.00 representing 100% downside risk from its current price of $1.77.

Fair Value

  • According to the consensus of 4 analysts, Montauk Renewables, Inc. has 67.37% upside to fair value with a price target of $2.96 per share.

MNTK vs. S&P 500

  • Over the past 5 trading days, Montauk Renewables, Inc. has overperformed the S&P 500 by 11.19% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Montauk Renewables, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Montauk Renewables, Inc. revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Montauk Renewables, Inc. reported revenues of $45.3M.

Earnings Growth

  • Montauk Renewables, Inc. earnings have been falling on a year-over-year basis for 4 quarters in a row. In the most recent quarter Montauk Renewables, Inc. reported earnings per share of $0.04.
Enterprise value:
318M
EV / Invested capital:
0.95x
Price / LTM sales:
1.57x
EV / EBIT:
19.69x
EV / Revenue:
1.98x
PEG ratio (5yr expected):
0.34x
EV / Free cash flow:
-5.96x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
13.48x
Gross Profit (TTM):
$57.9M
Return On Assets:
-2.46%
Net Income Margin (TTM):
-5.72%
Return On Equity:
-3.52%
Return On Invested Capital:
-2.8%
Operating Margin:
9.93%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $178.7M $194.8M $160.7M $65.9M $45.3M
Gross Profit $99M $107.4M $57.9M $44.4M $19.4M
Operating Income $29.2M $35M -$4.5M $23.2M $4.5M
EBITDA $50.7M $57.8M $23.6M $29.3M $12.8M
Diluted EPS $0.11 $0.16 -$0.06 $0.12 $0.04
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $39.4M $121.7M $107.4M $79.3M $18M
Total Assets $259.7M $323.9M $345.6M $374.1M $383.3M
Current Liabilities $29M $30.3M $30.2M $38.9M $53.9M
Total Liabilities $85.7M $105.1M $102.4M $98.8M $122.6M
Total Equity $174.1M $218.8M $243.2M $275.3M $260.7M
Total Debt $59.1M $73.5M $69.7M $61.6M $70.5M
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations $40.8M $64.5M $30.7M $28.6M $12.7M
Cash From Investing -$54.9M -$71.8M -$87.3M -$12.6M -$31.8M
Cash From Financing -$8.2M -$11M $8.3M -$3.3M -$3.2M
Free Cash Flow -$14.1M -$7.3M -$53.4M $16M -$17.2M
MNTK
Sector
Market Cap
$251.8M
$3.5B
Price % of 52-Week High
35.69%
89.52%
Dividend Yield
0%
2.77%
Shareholder Yield
-0.47%
1.21%
1-Year Price Total Return
-55.75%
5.6%
Beta (5-Year)
--
0.410
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Buy
Level $1.66
200-day SMA
Sell
Level $2.20
Bollinger Bands (100)
Sell
Level 1.84 - 2.24
Chaikin Money Flow
Sell
Level -11.1M
20-day SMA
Buy
Level $1.75
Relative Strength Index (RSI14)
Sell
Level 48.18
ADX Line
Sell
Level 21.41
Williams %R
Neutral
Level -48.7805
50-day SMA
Sell
Level $1.97
MACD (12, 26)
Sell
Level -0.09
25-day Aroon Oscillator
Sell
Level -16
On Balance Volume
Sell
Level -10.3M

Financial Scores

Buy
Altman Z-Score (Annual)
Level (3.8856)
Buy
CA Score (Annual)
Level (0.78)
Buy
Beneish M-Score (Annual)
Level (-3.1387)
Sell
Momentum Score
Level (1)
Buy
Ohlson Score
Level (-0.4977)
Buy
Piotroski F Score (Annual)
Level (5)
Buy
Quality Ratio Score
Level (7)
Sell
Fundamental Score
Level (6)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Montauk Renewables, Inc. engages in the recovery and processing of biogas from landfills and other non-fossil fuel sources for beneficial use as a replacement to fossil fuels. It operates through the Renewable Natural Gas and Renewable Electricity Generation segments. The Renewable Natural Gas segment deals with the production of renewable natural gas. The Renewable Electricity Generation segment includes generation of electricity at biogas-to-electricity plants. The company was founded in 1980 and is headquartered in Pittsburgh, PA.

Stock Forecast FAQ

In the current month, MNTK has received 0 Buy ratings 3 Hold ratings, and 1 Sell ratings. The MNTK average analyst price target in the past 3 months is $2.96.

  • Where Will Montauk Renewables, Inc. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Montauk Renewables, Inc. share price will rise to $2.96 per share over the next 12 months.

  • What Do Analysts Say About Montauk Renewables, Inc.?

    Analysts are divided on their view about Montauk Renewables, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Sell. However, a smaller subset of analysts suggest that Montauk Renewables, Inc. is a Buy and believe this share price will drop from its current level to $4.00.

  • What Is Montauk Renewables, Inc.'s Price Target?

    The price target for Montauk Renewables, Inc. over the next 1-year time period is forecast to be $2.96 according to 4 Wall Street analysts, 0 of them rate the stock a Buy, 1 rates the stock a Sell, and 3 analysts rate the stock a Hold.

  • Is MNTK A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Montauk Renewables, Inc. is a Hold. 3 of 4 analysts rate the stock a Hold at this time.

  • How Can I Buy Shares Of MNTK?

    You can purchase shares of Montauk Renewables, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Montauk Renewables, Inc. shares.

  • What Is The Montauk Renewables, Inc. Share Price Today?

    Montauk Renewables, Inc. was last trading at $1.78 per share. This represents the most recent stock quote for Montauk Renewables, Inc.. Yesterday, Montauk Renewables, Inc. closed at $1.77 per share.

  • How To Buy Montauk Renewables, Inc. Stock Online?

    In order to purchase Montauk Renewables, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Google Vs NVIDIA Stock: Which Is Best?
Google Vs NVIDIA Stock: Which Is Best?

Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…

How High Could NVIDIA Stock Go?
How High Could NVIDIA Stock Go?

NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 62x

Buy
61
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 38x

Buy
63
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 40x

Alerts

Buy
54
SMX alert for Dec 5

SMX (Security Matters) Plc [SMX] is up 154.74% over the past day.

Sell
15
HOV alert for Dec 5

Hovnanian Enterprises, Inc. [HOV] is down 22.58% over the past day.

Buy
67
NUTX alert for Dec 5

Nutex Health, Inc. [NUTX] is up 18.9% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock